Welcome Guest user | Login via Athens or your home institution
Resources
Register
For Authors
For Librarians
For Advertisers
eBooks
Services
Subscriptions/Pricing
Reprints
Advertising
Press Releases/News
Help
Downloads/Links
Online Submission
2012 Catalogue
Library Recommendation
Future Science Group
 

Summary
May 2010, Vol. 5, No. 3, Pages 345-363 , DOI 10.2217/rme.10.21
(doi:10.2217/rme.10.21)

Research Article

Spontaneous reversal of the developmental aging of normal human cells following transcriptional reprogramming

H Vaziri​‌, KB Chapman​‌, A Guigova​‌, J Teichroeb​‌, MD Lacher​‌, H Sternberg​‌, I Singec​‌, L Briggs​‌, J Wheeler​‌, J Sampathkumar​‌, R Gonzalez​‌, D Larocca​‌, J Murai​‌, E Snyder​‌, WH Andrews​‌, WD Funk​‌ & MD West​‌
† Author for correspondence



Aim: To determine whether transcriptional reprogramming is capable of reversing the developmental aging of normal human somatic cells to an embryonic state. Materials & methods: An isogenic system was utilized to facilitate an accurate assessment of the reprogramming of telomere restriction fragment (TRF) length of aged differentiated cells to that of the human embryonic stem (hES) cell line from which they were originally derived. An hES-derived mortal clonal cell strain EN13 was reprogrammed by SOX2, OCT4 and KLF4. The six resulting induced pluripotent stem (iPS) cell lines were surveyed for telomere length, telomerase activity and telomere-related gene expression. In addition, we measured all these parameters in widely-used hES and iPS cell lines and compared the results to those obtained in the six new isogenic iPS cell lines. Results: We observed variable but relatively long TRF lengths in three widely studied hES cell lines (16.09–21.1 kb) but markedly shorter TRF lengths (6.4–12.6 kb) in five similarly widely studied iPS cell lines. Transcriptome analysis comparing these hES and iPS cell lines showed modest variation in a small subset of genes implicated in telomere length regulation. However, iPS cell lines consistently showed reduced levels of telomerase activity compared with hES cell lines. In order to verify these results in an isogenic background, we generated six iPS cell clones from the hES-derived cell line EN13. These iPS cell clones showed initial telomere lengths comparable to the parental EN13 cells, had telomerase activity, expressed embryonic stem cell markers and had a telomere-related transcriptome similar to hES cells. Subsequent culture of five out of six lines generally showed telomere shortening to lengths similar to that observed in the widely distributed iPS lines. However, the clone EH3, with relatively high levels of telomerase activity, progressively increased TRF length over 60 days of serial culture back to that of the parental hES cell line. Conclusion: Prematurely aged (shortened) telomeres appears to be a common feature of iPS cells created by current pluripotency protocols. However, the spontaneous appearance of lines that express sufficient telomerase activity to extend telomere length may allow the reversal of developmental aging in human cells for use in regenerative medicine.

Full Text PDF (7796 KB) PDF Plus (7815 KB)

Cited by

, , , , , , , , , , , , , , , , , , . (2011) Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells. Cell Research
Online publication date: 20-Dec-2011.
CrossRef
, . (2011) Stem Cell Transplantation for Motor Neuron Disease: Current Approaches and Future Perspectives. Neurotherapeutics
Online publication date: 9-Sep-2011.
CrossRef
, . (2011) Telomere dynamics in dyskeratosis congenita: the long and the short of iPS. Cell Research
Online publication date: 26-Jul-2011.
CrossRef
, . (2011) Induced pluripotent stem cells: a new revolution for clinical neurology?. The Lancet Neurology 10:4, 383-394
Online publication date: 1-Apr-2011.
CrossRef
, , , , , , , , , , , , . (2011) Association of telomere length with authentic pluripotency of ES/iPS cells. Cell Research
Online publication date: 1-Feb-2011.
CrossRef
, . (2011) Present state and future perspectives of using pluripotent stem cells in toxicology research. Archives of Toxicology
Online publication date: 12-Jan-2011.
CrossRef
, , , , . (2011) The Year in Regenerative Medicine. Regenerative Medicine 6:1, 21-30
Online publication date: 1-Jan-2011.
Citation | Full Text | PDF (451 KB) | PDF Plus (452 KB)  | Reprints & Permissions
, , . (2011) Human iPS-Derived Retinal Pigment Epithelium (RPE) Cells Exhibit Ion Transport, Membrane Potential, Polarized VEGF Secretion and Gene Expression Pattern Similar to Native RPE. STEM CELLSN/A-N/A
Online publication date: 1-Jan-2011.
CrossRef
, , . (2011) Pluripotent stem cell heterogeneity and the evolving role of proteomic technologies in stem cell biology. PROTEOMICSn/a-n/a
Online publication date: 1-Jan-2011.
CrossRef
, , , . (2010) Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues. Journal of The Royal Society Interface 7:Suppl_6, S689-S706
Online publication date: 6-Dec-2010.
CrossRef
. (2010) The Janus face of pluripotent stem cells - Connection between pluripotency and tumourigenicity. BioEssays 32:11, 993-1002
Online publication date: 1-Nov-2010.
CrossRef
, . (2010) Back to immortality: the restoration of embryonic telomere length during induced pluripotency. Regenerative Medicine 5:4, 485-488
Online publication date: 1-Jul-2010.
Citation | Full Text | PDF (961 KB) | PDF Plus (962 KB)  | Reprints & Permissions
. (2010) Industry Update: Latest developments in stem cell research and regenerative medicine. Regenerative Medicine 5:4, 607-615
Online publication date: 1-Jul-2010.
Citation | Full Text | PDF (461 KB) | PDF Plus (464 KB)  | Reprints & Permissions
 

Prev. Article | Next Article
View/Print PDF (7796 KB)
View PDF Plus (7815 KB)
Add to favorites
Email to a friend
TOC Alert | Citation Alert What is RSS?

Quick Search
for
Authors:
H Vaziri
KB Chapman
A Guigova
J Teichroeb
MD Lacher
H Sternberg
I Singec
L Briggs
J Wheeler
J Sampathkumar
R Gonzalez
D Larocca
J Murai
E Snyder
WH Andrews
WD Funk
MD West
Keywords:
cellular aging
human embryonic stem cells
iPS cells
reprogramming
telomerase
telomeres